A DNA-PK phosphorylation site on MET regulates its signaling interface with the DNA damage response.
Jonas Paul KochSelina M RothAurélie QuintinJacopo GaviniEleonora OrlandoRahel RiedoChiara PozzatoLiana HayrapetyanRuedi AebersoldDeborah M StrokaDaniel M AebersoldMatúš MedoYitzhak ZimmerMichaela MedováPublished in: Oncogene (2023)
The DNA damage response (DDR) is intertwined with signaling pathways downstream of oncogenic receptor tyrosine kinases (RTKs). To drive research into the application of targeted therapies as radiosensitizers, a better understanding of this molecular crosstalk is necessary. We present here the characterization of a previously unreported MET RTK phosphosite, Serine 1016 (S1016) that represents a potential DDR-MET interface. MET S1016 phosphorylation increases in response to irradiation and is mainly targeted by DNA-dependent protein kinase (DNA-PK). Phosphoproteomics unveils an impact of the S1016A substitution on the overall long-term cell cycle regulation following DNA damage. Accordingly, the abrogation of this phosphosite strongly perturbs the phosphorylation of proteins involved in the cell cycle and formation of the mitotic spindle, enabling cells to bypass a G2 arrest upon irradiation and leading to the entry into mitosis despite compromised genome integrity. This results in the formation of abnormal mitotic spindles and a lower proliferation rate. Altogether, the current data uncover a novel signaling mechanism through which the DDR uses a growth factor receptor system for regulating and maintaining genome stability.
Keyphrases
- cell cycle
- dna damage response
- protein kinase
- growth factor
- dna repair
- circulating tumor
- dna damage
- cell proliferation
- tyrosine kinase
- single molecule
- cell free
- signaling pathway
- induced apoptosis
- pi k akt
- genome wide
- oxidative stress
- cell cycle arrest
- big data
- nucleic acid
- transcription factor
- artificial intelligence
- machine learning
- radiation induced
- drug delivery
- dna methylation
- epithelial mesenchymal transition
- cell death
- gene expression
- cancer therapy